Sign in

Private company

Nemaura Medical Inc.

Nemaura Medical Inc. is a surgical and medical instruments and apparatus company.1 It is headquartered in Manhattan, New York.1

Last updated Oct 21, 2026.

Overview

$77.0KRevenue, fiscal 20232
-$14.1MNet income, fiscal 20232
  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersManhattan, New York1
  • Business address57 West 57Th Street, Manhattan, Ny 100193
  • Filer categoryNon-accelerated filer, Smaller reporting company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

-1916.3%Gross margin2
-12454.2%Operating margin2
-18358.0%Net margin2
-84.7%Revenue growth, 20232
-$8.8MFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue5¢$75.3K
  • Research and development95¢$1.5M

Out of $77.0K in revenue.2 The company lost money this year.

Financial statements

Revenue456782$77.0K in 2023
0$200.0K$400.0K$600.0K2016: $0$020162017: $0$020172018: $0$020182019: $0$020192020: $0$020202021: $0$020212022: $503.9K$503.9K20222023: $77.0K$77.0K2023−85%
Gross profit82-$1.5M in 2023
-$1.5M-$1.0M-$500.0K0$500.0K2021: $0$020212022: $159.6K$159.6K20222023: -$1.5M-$1.5M2023
Operating income456782-$9.6M in 2023+523% since 2016
-$10.0M-$7.5M-$5.0M-$2.5M02016: -$1.5M-$1.5M20162017: -$1.6M-$1.6M2017+1%2018: -$1.9M-$1.9M2018+23%2019: -$4.5M-$4.5M2019+135%2020: -$4.8M-$4.8M2020+7%2021: -$4.6M-$4.6M2021−4%2022: -$7.6M-$7.6M2022+65%2023: -$9.6M-$9.6M2023+27%
Net income456782-$14.1M in 2023+819% since 2016
-$15.0M-$10.0M-$5.0M02016: -$1.5M-$1.5M20162017: -$1.6M-$1.6M2017+1%2018: -$1.8M-$1.8M2018+17%2019: -$4.5M-$4.5M2019+145%2020: -$4.2M-$4.2M2020−7%2021: -$6.3M-$6.3M2021+50%2022: -$13.9M-$13.9M2022+122%2023: -$14.1M-$14.1M2023+2%
Fiscal year20162017201820192020202120222023
Revenue$04$05$05$06$07$08$503.9K2$77.0K2
Cost of revenue$08$344.3K2$75.3K2
Gross profit$08$159.6K2-$1.5M2
Research and development$1.0M4$1.0M5$993.8K5$2.3M6$2.0M7$1.6M8$1.6M2$1.5M2
Operating expenses$7.7M2$8.1M2
Operating income-$1.5M4-$1.6M5-$1.9M5-$4.5M6-$4.8M7-$4.6M8-$7.6M2-$9.6M2
Income before tax-$14.2M2-$14.1M2
Income tax$04$05$05$06-$614.4K7-$335.8K8-$350.3K2$02
Net income-$1.5M4-$1.6M5-$1.8M5-$4.5M6-$4.2M7-$6.3M8-$13.9M2-$14.1M2
Earnings per share-$0.592-$0.572
Earnings per share (diluted)-$0.592-$0.572
Shares (weighted, basic)23.4M shares224.9M shares2
Shares (weighted, diluted)23.4M shares224.9M shares2

Compare Nemaura Medical Inc. with another company

Corporate structure

Nemaura Medical Inc. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Nemaura Medical Inc.

  • Nemaura Medical Inc. Manhattan, New York

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Nemaura Medical Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Machinery and equipment$998.6K2 Mar 31, 2023$727.2K2 Mar 31, 2022+37.3%
Furniture and fixtures$114.9K2 Mar 31, 2023$78.9K2 Mar 31, 2022+45.6%
Computer equipment and software$655.6K2 Mar 31, 2023
Property and equipment, before depreciation$1.1M2 Mar 31, 2023$806.1K2 Mar 31, 2022+38.1%
Accumulated depreciation$471.6K2 Mar 31, 2023$273.6K2 Mar 31, 2022+72.4%
Property and equipment, net$641.9K2 Mar 31, 2023$532.5K2 Mar 31, 2022+20.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$10.1M2 Mar 31, 2023$17.7M2 Mar 31, 2022−43.1%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$384.1K2 Mar 31, 2023$1.5M2 Mar 31, 2022−74.1%
Finite-lived intangibles, gross$897.2K8 Mar 31, 2022$391.5K8 Mar 31, 2021+129.2%
Accumulated amortization$186.9K8 Mar 31, 2022$125.4K8 Mar 31, 2021+49.0%
Finite-lived intangibles, net$384.1K2 Mar 31, 2023$1.5M2 Mar 31, 2022−74.1%
Patents, net$1.1M8 Mar 31, 2022$516.9K8 Mar 31, 2021+109.7%

Inventory

ItemLatestA year beforeChange
Inventory, total$1.8M2 Mar 31, 2023$1.5M2 Mar 31, 2022+18.0%
Raw materials$1.6M2 Mar 31, 2023$1.5M2 Mar 31, 2022+7.1%
Finished goods$168.1K2 Mar 31, 2023$5.8K2 Mar 31, 2022+2785.4%

Leadership

Who has led Nemaura Medical Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Dewan Fazlul Hoque Chowdhury2014–2022

President

  1. Dewan Fazlul Hoque Chowdhury2014–2022

Chief financial officer

  1. Iain Anderson2018
  2. Justin James McLarney2021–2022

Chief operating officer

  1. Arash Ghadar-Ghadr2024
201520202025
Board members and other officers (7)

Timeline

  1. Sep 26, 20248-K Executive or director change; Regulation FD disclosure24
  2. May 17, 20248-K Shareholder vote25
  3. Apr 22, 20248-K Bylaws or fiscal year changed26
  4. Apr 10, 20248-K Entered a material agreement; Unregistered sale of shares; Executive or director change27
  5. Feb 26, 20248-K Shareholder vote28
  6. Jan 3, 20248-K Regulation FD disclosure29
  7. Jan 3, 20248-K Listing notice or transfer30
  8. Dec 13, 20238-K Regulation FD disclosure31
  9. Nov 21, 20238-K Entered a material agreement; New debt or obligation; Regulation FD disclosure32
  10. Nov 14, 20238-K Regulation FD disclosure33
  11. Nov 14, 20238-K Regulation FD disclosure34
  12. Nov 13, 20238-K Results of operations35
  13. Dec 23, 2014New chief executive Dewan Fazlul Hoque Chowdhury becomes CEO14

Calendar

When it reported results

  1. Nov 13, 2023Reported quarterly or annual results35
  2. Aug 14, 2023Reported quarterly or annual results36
  3. Jul 14, 2023Reported quarterly or annual results37
  4. Nov 14, 2022Reported quarterly or annual results38
  5. Jul 1, 2022Reported quarterly or annual results39
  6. Nov 15, 2021Reported quarterly or annual results40

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

101 filings to the SEC since October 2021: 3 annual reports, 10 quarterly reports, 44 major events, 11 insider forms, 1 large holders, 32 other. The latest 20:

  1. Sep 26, 20248-K EDGAR
  2. Jul 1, 2024DEF 14C DEFINITIVE 14C EDGAR
  3. Jul 1, 2024NT 10-K FORM 12B-25 EDGAR
  4. May 17, 20248-K EDGAR
  5. Apr 22, 20248-K EDGAR
  6. Apr 19, 2024PRE 14C EDGAR
  7. Apr 10, 20248-K EDGAR
  8. Feb 26, 20248-K EDGAR
  9. Feb 14, 2024SC 13G EDGAR
  10. Feb 12, 202410-Q EDGAR
  11. Jan 17, 2024DEFA14A DEFINITIVE 14A ADDTIONAL MATERIALS EDGAR
  12. Jan 17, 2024DEF 14A DEFINITIVE 14A EDGAR
  13. Jan 9, 20244 EDGAR
  14. Jan 9, 20243 EDGAR
  15. Jan 3, 20248-K EDGAR
  16. Jan 3, 20248-K EDGAR
  17. Dec 13, 20238-K EDGAR
  18. Dec 7, 2023PRE 14A PRELIMINARY 14A EDGAR
  19. Nov 21, 20238-K EDGAR
  20. Nov 14, 20238-K EDGAR

The 101 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

1 open-market trades by officers, directors and large owners since October 2021: 1 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jan 5, 2024Ghadar-Ghadr ArashChief Operating OfficerBuy100,000$0.14$14.0KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Nemaura Medical Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARNemaura Medical Inc.1
  • CIK0001602078
  • Employer ID (EIN)46-50272601
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Fiscal year endsMarch 311
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address57 West 57Th Street, Manhattan, NY 100191
  • Phone44-1509-222-9121
  • Shares outstanding28,899,402 as of Feb 12, 202411
  • Public float$25.2M as of Mar 31, 20232
  • On EDGAR sinceMar 28, 20141
  • Filings276 in all: 8-K (123), 10-Q (30), 4 (13), 3 (12), UPLOAD (12), 424B5 (10), 10-K (9), CORRESP (9)1
    All 33 form types

    S-1/A (7), DEF 14A (6), EFFECT (6), CT ORDER (3), DEF 14C (3), NT 10-K (3), PRE 14C (3), S-3 (3), 10-K/A (2), 10-Q/A (2), 8-K/A (2), DEFA14A (2), PRE 14A (2), S-1 (2), SC 13G (2), 25-NSE (1), 424B3 (1), 424B4 (1), 424B8 (1), 8-A12B (1), 8-A12G (1), CERT (1), NT 10-Q (1), POS AM (1), S-3/A (1)

  • Latest filingsAnnual report (10-K) Jul 13, 2023
    Quarterly report (10-Q) Feb 12, 2024
    Proxy statement (DEF 14A) Jan 17, 2024
    Latest 8-K (8-K) Sep 26, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41